Background: In Japan, there has been a lot of reports showing an association between facial flushing after light alcohol consumption and heterozygosity for inactive aldehyde dehydrogenase-2 (ALDH2). Persons with inactive ALDH2 may have a higher risk of alcohol-related oral, pharyngeal and esophageal cancers, compared with those with wild-type ALDH2. The purpose of this study was to examine whether flushers with oral or pharyngeal squamous cell carcinoma have an increased risk of synchronous or metachronous cancer of the upper gastrointestinal (UGI) tract. Methods: A retrospective study was performed by medical chart review and through a questionnaire sent to 285 patients treated for oral and pharyngeal cancer. Responses were obtained from 150 patients (52.6%), who were classified as flushers or non-flushers, smokers (≥20 pack-year; 1 pack-years = number of cigarettes/20 per day) or non-smokers, and drinkers (≥14 units of alcohol consumption per week; 1 unit = 22 g) or non-drinkers. Relationships of these factors with occurrence of second primary cancers (SPCs) in the UGI tract were investigated. Results: In Kaplan-Meier analysis, there was a significantly higher rate of SPC at 5 years in flushers and drinkers, but no relationship with smoking. In multivariate analyses, a history of flushing was significantly associated with SPC in the UGI tract (HR 2.64, 95% CI 1.25-5.52, P = 0.0109), but not with smoking or alcohol consumption. Conclusions: A simple interview on history of facial flushing after alcohol intake can be useful for identifying patients at high risk for synchronous or metachronous cancers of the UGI tract.
Introduction
Smoking and alcohol intake are well-established risk factors for head and neck squamous cell carcinoma (HNSCC). However, heavy smokers and drinkers do not always develop cancer and the effects of these factors seem to vary among individuals. In Japan, there has been a lot of past papers reporting that past or current facial flushing after intake of a small amount of alcohol (flushers) has been associated with inactive heterozygous aldehyde dehydrogenase-2 (ALDH2), and such individuals may have higher relative risks of alcohol-related oral, pharyngeal and esophageal cancers, compared with individuals with wild-type ALDH2 alleles (1, 2) .
A further important clinical observation is that carcinomas in the upper gastrointestinal (UGI) tract often lead to secondary primary cancers (SPCs) during or after treatment. Thus, a patient with newly diagnosed HNSCC at our institution is required to undergo FDG-PET and upper gastrointestinal endoscopy before treatment to detect possible synchronous cancers because the progression and site of synchronous cancers may alter the sequence and course of treatment (3) . Similarly to metachronous cancers, surveillance for identifying patients at high risk for cancers is also important because early detection can contribute to use of less-invasive therapy and improve prognosis.
Since flushers may be at risk for UGI tract multiple cancers, the purpose of this study was to examine whether flushers with oral and pharyngeal squamous cell carcinoma have a higher risk for synchronous or metachronous cancer of the UGI tract and to clarify the relationship between risks associated with flushing and those associated with alcohol and smoking.
Patients and methods

Subjects
A retrospective study was conducted by questionnaire and medical chart review in 285 Japanese patients with oral or pharyngeal (but not nasopharyngeal) SCC who were treated in the Department of Otolaryngology-Head and Neck Surgery at Kobe City Medical Center General Hospital between January 2004 and December 2012. All patients had been diagnosed at least 4.5 years before the start of the study. None had a history of oral or pharyngeal cancer prior to diagnosis. The study was approved by the Ethics Committee of Kobe City Medical Center General Hospital.
Questionnaire
A questionnaire (Fig. 1 ) was sent to 285 patients to request information on current and past flushing reactions to intake of small amounts of alcohol, and on smoking and drinking habits. The questions on flushing (2(A) and (B) in Fig. 1 ) were designed to identify individuals with inactive ALDH2, and have been shown to have 90% sensitivity and 88% specificity for this purpose (4) . The patients who answered Yes in either of Question A (former flusher) or Question B (current flusher) were defined as flushers (5) . Ethanol consumption per week was calculated using a standard conversion for alcoholic beverages, in which beer is estimated to be 5% ethanol, wine 12%, sake 15%, shochu 25% and whisky 40%. Weekly ethanol consumption was converted into number of units, where 1 unit was defined as the standard ethanol content of one serving of sake. Responses to the questionnaire were obtained from 150 patients (52.6%), who were enrolled as subjects in this study. These subjects included 32 deceased patients for whom their families answered the questionnaire. Out of 135 patients who did not respond to the questionnaire, 22 patients were alive, 64 patients died and 49 patients dropped out of observation.
Based on the questionnaire data, subjects were classified as flushers or non-flushers (see above), smokers (≥20 pack-years; 1 pack-years = number of cigarettes/20 per day × number of years of smoking) or non-smokers (6,7), and drinkers (≥14 units of alcohol consumption per week; 1 unit = 22 g) or non-drinkers (8) (9) (10) , and relationships of these groups with occurrence of SPC in the UGI tract were evaluated.
Definitions of tumors
Multiple primary malignant tumors were defined using the modified criteria of Warren et al. (11, 12) , which require that both tumors are histologically malignant, are separated by at least 2 cm of normal healthy mucosa, and the possibility of the second tumor being a metastasis is excluded. Synchronous malignant tumors were defined as presenting simultaneously or within a 6-month period after identification of the original tumor, whereas metachronous malignant tumors were diagnosed more than 6 months after the index tumor, as defined by Gluckman et al. (3) . For counting of multiple cancers, the index oral or pharyngeal cancer was defined as the first cancer and the following cancer in the UGI tract (oral to stomach) was defined as the SPC. For triple cancers or more, the third and subsequent cancers were not counted.
Statistical analysis
The Kaplan-Meier method and a log-rank test were used to analyze the difference in the cumulative occurrence of SPC in the UGI tract between two groups. A Cox regression model was used for univariate and multivariate analysis to calculate a hazard ratio (HR). All analyses were performed with Excel Tokei 2012 and P < 0.05 was regarded as significant.
Results
The characteristics of the 150 subjects (105 males, 45 females; median age 65 years) are listed in Table 1 . In total there were 19 patients who had synchronous cancers and 42 patients who developed metachronous cancers. The patients without any of SPC were counted as 89. The follow-up period ranged from 0.22 years (80 days) to 12.1 years, with a median of 4.99 years. Of the 150 all subjects, 108 (72%) were smokers, 94 (63%) were drinkers and 72 (48%) were flushers.
Among 61 patients who had synchronous or metachronous cancers, 36 (24% of all patients) had SPC in the UGI tract, including synchronous cancers in 13 patients (8.7%) and metachronous cancers in 23 patients (15.3%). The most common primary and SPC combination was hypopharyngeal cancer and esophageal cancer (n = 12), followed by oral cancer and oral cancer (n = 6). For synchronous cancers in the UGI tract, the most common was hypopharyngeal cancer, which was found in 12 of 20 patients (Table 2) . For metachronous cancers, the time to SPC onset after diagnosis of the primary cancer was 0.52 years (189 days) to 11.2 years, with mean time of 4.72 years.
Kaplan-Meier analysis and a log-rank test showed a significantly higher 5-year cumulative rate of SPC in the UGI tract in flushers compared with non-flushers (32.4% vs. 11.1%, P = 0.0135) (Fig. 2a) and in drinkers compared with non-drinkers (26.6% vs. 13.9%, P = 0.0364) (Fig. 2b) , but not in smokers compared with non-smokers (Fig. 2c) . In subsequent Kaplan-Meier analysis of flushing reaction and alcohol intake only, the 5-year SPC rate was significantly higher in persons who were both flushers and drinkers, at 37.9% (Fig. 3) .
Interestingly, flusher and drinker demonstrated significant higher 5-year SPC rate than flusher and non-drinker (P = 0.0496), which suggested that drinking cessation may reduce the risk of SPC.
Univariate analysis showed that flusher, alcohol intake and with a hypopharyngeal site of the primary cancer were significant risk factors of SPC in the UGI. However, multivariate analysis using a Cox proportional hazards model showed that SPC in the UGI tract was significantly and independently associated with a history of flushing (HR: 2.62, 95% CI: 1.25-5.52, P = 0.011), but not with smoking or alcohol intake, and with a hypopharyngeal site of the primary cancer (HR: 4.86, 95% CI: 2.19-10.8, P < 0.001) ( Table 3) .
Discussion
This study suggests that a patient with oral or pharyngeal cancer who is identified as a flusher via a simple questionnaire is at high risk for onset of SPC in the UGI tract. HNSCCs including oral and pharyngeal cancer are well known for developing local recurrent cancers and synchronous or metachronous cancers in the UGI tract during or after treatment (11) . This phenomenon is often explained by 'Slaughter's field cancerization' concept (13) , in which it is proposed that a sequential area with cancer has been preconditioned by a carcinogen.
Acetaldehyde metabolized by alcohol dehydrogenase (ADH) is a carcinogen in the UGI tract (14, 15) . Ethanol in vivo is degraded in three stages: ethanol to acetaldehyde by ADH, acetaldehyde to acetic acid by acetaldehyde dehydrogenase (ALDH), and acetic acid to acetyl-COA by several enzymes. Homozygous and heterozygous inactive ALDH2 is present in~7% and 35% of Japanese people, respectively (16) and after drinking these individuals havẽ 19 and 6 times higher blood peaks of acetaldehyde, respectively, compared with people with wild-type ALDH2 alleles (17, 18) . Those with homozygous inactive ALDH2 tend to have severe acetaldehydemia after drinking and usually become non-drinkers because of adverse events such as nausea, drowsiness, tachycardia and flushing. In contrast, those with heterozygous inactive ALDH2 can develop tolerance to acetaldehydemia by regular drinking and may become heavy drinkers, which increases their risk of cancer in the UGI due to long-term exposure to acetaldehyde caused by habitual drinking (19) . The sensitivity and specificity of the simple flushing questionnaire are high for detection of inactive ALDH2, but there is not a perfect match between flushers and persons with inactive ALDH2. The incomplete match of the questionnaire and ALDH2 polymorphism is partly due to the presence of ADH1B polymorphisms that cause individuals to be poor metabolizers of ethanol to acetaldehyde. Those with heterozygous inactive ALDH2 and inactive ADH1B are nonflushers and have a high level of ethanol. As a result, they tend to be heavy drinkers due to their tolerance to acetaldehydemia and dependency on alcohol. Such an individual has a 30-40 times higher risk of esophageal cancer than an individual with active ALDH2 and active ADH1B (5, 8) . However, the only current procedure for identifying inactive ADH1B is genetic analysis.
Stomach cancer, which is an adenocarcinoma and thus differs from SCC, was included as a SPC because the frequency of synchronous and metachronous stomach cancer and HNSCC is high among Japanese alcoholics with esophageal cancer (20) . The International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) found no definitive evidence for a link between alcohol consumption and stomach cancer (21) . However, one study suggested that Japanese people with a high infection rate of Helicobacter pylori increase their risk of stomach cancer by heavy drinking (5) . Regarding the flushing response, a Japan Public Health Center-based prospective study suggested a possible relationship between inactive ALDH2 and stomach cancer (22, 23) .
The questionnaire results in this study showed that 48% of 150 patients were flushers, which is close to the rate found epidemiologically in Japan. But in 36 patients with oral or pharyngeal cancer who had cancers in the UGI tract, 26 (72%) were flushers, which is a higher rate than expected.
Flushers and drinkers had a significantly higher cumulative rate of SPC in the UGI tract, which suggests that a flushing reaction in drinkers obtained by interview is a risk for SPC. Comparing with flushers and drinkers, flushers and non-drinkers demonstrated significant lower SPC rate than flushers and drinkers, which suggested that even for flushers, drinking cessation may reduce the risk of SPC. In a study of the association of alcohol intake cessation with risk reduction for esophageal and head and neck cancer, the horizontal axis in Kaplan-Meier curves covered a period of 9 years and the risk was only reduced after 10-year cessation in pooled analysis (10) . However, recent paper proved that the incidence rate of metachronous esophageal carcinoma decreased after relatively short time of drinking cessation in the flusher and drinker group (24) . Multivariate analysis showed that flushers and hypopharyngeal cancer were significant independent risk factors for SPC in the UGI tract. Human papilloma virus (HPV)-related oral or oropharyngeal cancer is unlikely to lead to multiple primary cancer due to its different carcinogenesis mechanism (25) .
Unfortunately, we did not examine HPV infectiousness for all patients with oral or oropharyngeal SCC and our series of the patients may include some of HPV-related oral or oropharyngeal cancers. The common synchronous cancers in the UGI tract were hypopharyngeal and esophageal cancers, which suggests that 'field cancerization' occurs around the same time and frequently in the hypopharynx and esophagus areas. Advances in cancer treatment have improved prognosis and increased life expectancy, even for patients with multiple cancers. Complete recovery from cancer is assisted by detection at an early stage.
Thus, in summary, it seems that a flusher with hypopharyngeal cancer requires particular follow-up for detection of esophageal cancer, and that the risk of development of multiple cancers in flushers with oral or pharyngeal cancer can be reduced through sharing the knowledge of etiology about alcohol drinking and flushing phenomenon with patients.
There were a number of limitations to this study. We were unable to confirm the genetic backgrounds of ALDH2 allele for flushers patients. We also included only patients who responded to our questionnaire. Indeed, there were more deceased patients among the cases who did not reply the questionnaire in spite that we tried to retrieve the data from deceased patients by asking the patients family to answer the questionnaire. Flushers tend to have superficial cancers rather than invasive cancer and have better survival rates than those who had invasive cancers. The population who did not reply the questionnaire might include more non-flushers who already died. The inclusion criteria may unintentionally yield some selection bias.
Conclusion
In Japanese patients with oral or pharyngeal cancer, a simple interview on history of facial flushing after intake of a small amount of alcohol may be useful for identifying those at high risk for multiple cancers, and awareness of this risk can prevent cancers through sharing the knowledge of the etiology with patients. The relationship of flushing with a risk for SPC in the UGI tract shown in this study requires confirmation, but the results suggest the need for more careful follow-up of patients who have a flushing response.
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